Clinical trial / 2013
Curcumin dose titration was well tolerated in children with inflammatory bowel disease.
Children and adolescents with mild or remissive Crohn disease or ulcerative colitis received adjunctive curcumin escalated every three weeks from 500 mg to 1 g and finally 2 g twice daily. Curcumin was tolerated well across the 9-week evaluation, with increased gassiness noted in only two participants across all visits. Additionally, three individuals experienced improvements in validated disease activity scores.
- Study type
- Prospective dose-titration study
- Who was studied
- Pediatric patients with Crohn disease or ulcerative colitis in remission or with mild disease
- What was measured
- Tolerability, side effects, and disease activity
THE PAPER
Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study.
Suskind DL, Wahbeh G, Burpee T, Cohen M, Christie D, Weber W. J Pediatr Gastroenterol Nutr, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.